| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/11/2001 | US6287864 Insertion of nucleotide sequences into preferential cells; infect hematopoietic stem cells with retrovirus, detect expression of preferential gene product |
| 09/11/2001 | US6287815 Spodoptera frugiperda cells produce vp1 capsid protein using a baculovirus expression system |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287570 Purified dna |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | CA2166889C Oligonucleotides with activity against human immunodeficiency virus |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064860A2 Recombinant influenza a viruses |
| 09/07/2001 | WO2001064846A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| 09/05/2001 | EP1130093A1 Oligonucleotide mediated nucleic acid recombination |
| 09/05/2001 | EP1130089A1 Composition comprising membrane virus subviral target and fusion particles and vaccine comprising said composition |
| 09/05/2001 | EP1129728A1 Methods and compositions for the selective modification of nucleic acids |
| 09/05/2001 | EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it |
| 09/05/2001 | EP1129722A1 gM-negative EHV-mutants |
| 09/05/2001 | EP1129178A1 A sensitive screening system for envelope-defective recombinant virus |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129100A1 Selection system for generating efficient packaging cells for lentiviral vectors |
| 09/05/2001 | EP0513090B1 Hepatitis a vaccines |
| 09/05/2001 | CN1311690A Porcine circovirus and parvovirus vaccine |
| 09/05/2001 | CN1311689A Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| 09/04/2001 | US6285919 Robotic system for retractable teleoperated arm within enclosed shell with capability of operating within a confined space |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284503 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | US6284254 Vaccines |
| 09/04/2001 | US6284251 Bovine herpes virus |
| 08/30/2001 | WO2001062981A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062970A1 Methods and compositions for identifying a protease |
| 08/30/2001 | WO2001062908A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 08/30/2001 | WO2001062827A2 N-maleimidyl polymer derivatives |
| 08/30/2001 | US20010018203 DNA construction: promoter, recombinase recogniton sequence, drug resistance gene, polyA addition signal, recombinase recognition signal, virus structural protein gene, polyA addition signal, in that order |
| 08/30/2001 | US20010018202 Lentiviral vectors derived from SIVagm, methods for their preparation and their use for gene transfer into mammalian cells |
| 08/30/2001 | CA2401623A1 Methods and compositions for identifying a protease |
| 08/30/2001 | CA2401018A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | CN1310767A Recombinant baculovirus-based insecticides |
| 08/29/2001 | CN1310765A Mutant herpes simplex viruses and uses thereof |
| 08/29/2001 | CN1070078C Process for producing vaccine of foot-and-mouth disease |
| 08/28/2001 | US6281010 Gene expression, engineering; packaging transgene; genetic disorders |
| 08/28/2001 | US6281000 Dna fragment cloning into genome of recombinant adenoviral plasmid vector; human gene therapy |
| 08/28/2001 | US6280970 Bird embryonic tissues; for use as diagnostic diagnostic tools or in vaccine development |
| 08/28/2001 | US6280940 Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
| 08/28/2001 | US6280734 Simian-human HAV having a chimeric 2C protein |
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/23/2001 | WO2001061022A1 Recombinant human papillomavirus vaccine expressed in transgenic plants |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060849A2 Cold-adapted equine influenza viruses |
| 08/23/2001 | WO2001060847A2 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001009290A3 Avian infectious bronchitis virus serotype |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2000077177A3 Isolation of a human retrovirus |
| 08/23/2001 | WO2000061737A3 Production of attenuated negative stranded RNA virus vaccines |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016347 Packaging cell |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124976A1 Improved aav vector production |
| 08/22/2001 | EP1124575A1 Method for the production of an antiviral agent |
| 08/21/2001 | US6277633 Lentivirus-based gene transfer vectors |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277600 Trimeric chimera protein and collagen matrix containing chimera protein |
| 08/21/2001 | US6277593 Generating preferential polypeptide; culture transformed cells, express preferential polypeptide, recover preferential polypeptide |
| 08/21/2001 | US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91) |
| 08/16/2001 | WO2001059125A1 Method of constructing temperature-sensitive morbilli virus |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059093A2 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 08/16/2001 | WO2001059085A1 Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light |
| 08/16/2001 | WO2001059077A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | WO2001058478A1 Antigenic complexes and methods |
| 08/16/2001 | WO2001027282A8 Plant virus particles with exogenous internal eitopes |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | US20010014456 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
| 08/16/2001 | EP1123390A2 Methods and reagents for isolating biologically active peptides |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP0827547B1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof |
| 08/16/2001 | EP0805877B1 Improved method of selecting specific bacteriophages |
| 08/16/2001 | EP0738106B1 Peracetic acid sterilization |
| 08/16/2001 | CA2400583A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399151A1 Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/15/2001 | CN1307902A Varicella preventing method using vaccine |
| 08/14/2001 | US6274354 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274147 Preparing cdna of infectious pancreatic necrosis virus genome, initiating replication of ds rna in host cell using rna derived from cdna, incubating host cell in culture medium, and isolating live, infectious pancreatic necrosis virus |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/09/2001 | WO2001057244A1 AN ASSAY FOR DETECTING VARIANT HAPATITIS B VIRUSES (HBVs) WHICH EXHIBIT ALTERED SENSITIVITY TO AGENTS |
| 08/09/2001 | WO2001057227A1 Process for producing telomere reverse transcriptase |
| 08/09/2001 | WO2001057204A1 Virus envelope vector for gene transfer |
| 08/09/2001 | WO2001057192A1 Diagnostic reagents and methods for antibody against hepatitis b surface antigen and for antibody against hepatitis b virus |